DEF201

DEF201 helps the host combat viral infections by using constitutively produced in situ human interferon protein; a proven broad spectrum antiviral with significant clinical success. DEF201 is composed of a replication defective Adenovirus vector which encodes the gene for the interferon alpha protein. Applied as a gentle nasal mist, DEF201 enters the cells lining your nose stimulate the host interferon system. In all the infectious viruses tested to date, only a single administration of intranasal DEF201, is required to provide sustained survival benefit in animal models.

Notify me on updates of this product 

Availability: In Development

Dana Rath
President, CEO & CFO, & Director
info@defyrus.com
+1 514 231 3554
2 Bloor Street West, Suite 2602
Toronto, ON M4W 3E2
Canada
www.defyrus.com/products_def201.html
Manufacturer
Defyrus, Inc.
Product Name
DEF201
Detection Category
Biological
Detection Method
Medical Countermeasure;
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
DEF201 helps the host combat viral infections by using constitutively produced in situ human interferon protein; a proven broad spectrum antiviral with significant clinical success. DEF201 is composed of a replication defective Adenovirus vector which encodes the gene for the interferon alpha protein. Applied as a gentle nasal mist, DEF201 enters the cells lining your nose stimulate the host interferon system. In all the infectious viruses tested to date, only a single administration of intranasal DEF201, is required to provide sustained survival benefit in animal models.
Availability
In Development
Technology Readiness Level (TRL)
7
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Transportability
Pocket Size
Live Agent Tested
Yes
Operating Time
Immediate post-exposure use
Training Required
<1 day training
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: